Requests of medical examinations after pneumococcal & influenza vaccination in the elderly

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 108-114

  D'Alessandro, Daniel ^a   Ciriminna, S ^b   Rossini, A ^a   Bossa, M C ^a   Fara, G M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Medical examinations; Pneumococcal and influenza vaccine; Tolerability

Indexed keywords

ANTIBIOTIC AGENT; CORTISONE; INFLUENZA VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE;

AGED; ANAPHYLAXIS; ARTHRALGIA; ARTICLE; CHILL; CONSULTATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FEVER; FREQUENCY ANALYSIS; GENERAL PRACTITIONER; HEADACHE; HEALTH PROGRAM; HUMAN; INJECTION PAIN; INJECTION SITE; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICAL EXAMINATION; MEDICAL RECORD; MYALGIA; PAIN; PRURITUS; RISK ASSESSMENT; RISK FACTOR; SKIN INDURATION; SKIN MANIFESTATION; SYMPTOMATOLOGY; TELEPHONE; VACCINATION; WINTER;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; PHYSICAL EXAMINATION; PNEUMOCOCCAL VACCINES;

EID: 3442883634     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Influenza and pneumococcal vaccination levels among persons aged ≥65 years - United States. 2001. MMWR Morb Mortal Wkly Rep 2002; 51: 1019-24.
2. http://demo.istat.it/previsioni/index.html
3. Pantosti A, D'Ambrosio F, Tarasi A, Recchia S, Orefici G, Mastrantonio P. Antibioic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitisi in Italy, 1997-1999. Clin Infect Dis 2000; 31: 1373-9.
4. Marchese A, Schito GC. Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents 2000; 16 Suppl 1: S25-S29.
5. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder P, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338: 1861-8.
6. John CC. Treatment failure with use of a third generation cephalosporin for penicillin resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18:188-93.
7. Honkanen PO, Keistinen T, Kivela S. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996; 156: 205-8.
8. Fletcher TJ, Tunnicliffe WS, Hammond K, Roberts K, Ayres JG. Simultaneous immunisation with influenza vaccine and pneumococcal polysaccaride vaccine in patients with chronic respiratory disease. BMJ 1997; 314: 1663.
9. Toniolo-Neto J, Weckx LW, Halker E, Lopes CH, de Menzes Succi RC, de Paiva TM, et al. Safety of simultaneous pneumococcal and influenza vaccination in elderly patients in Brazil. Drugs Aging 1999; 15 (Suppl 1): 43-5.
10. Grilli G, Fuiano L, Biasio LR, Pregliasco F, Plebani A, Leibovitz M, et al. Simultaneous influenza and pneumococcal vaccination in elderly individuals. Eur J Epidemiol 1997; 13: 287-91.
11. Fedson DS, Musher MD, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, 3rd ed. Philadelphia: Saunders; 1999 p. 553-607.
12. Ponka A, Leinonen M. Adverse reactions to polyvalent pneumococcal vaccine. Scand J Infect Dis 1982; 14: 67-71.
13. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46 (RR-8): 1-24.